SCHEMBL7174231

SCHEMBL7174231

CC(C)(C)C(NC(=O)C(Nc1ccc(-c2ccccc2)cc1)C(O)C(=O)NO)C(=O)N1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.45
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.38
ADAM17 P78536 3/20 0.38
MMP1 P03956 1/20 0.38
MAPT P10636 1/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
TACR1 P25103 2/20 0.37
FCER2 P06734 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
MMP2 P08253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7170637 0.91 ALOX15 (0.45) MMP8ALOX15HSD17B10SMN1; SMN2MMP1
SCHEMBL7306891 0.90 ALDH1A1 (0.43) MMP8ALOX15HSD17B10SMN1; SMN2ADAM17
SCHEMBL7174032 0.84 ADAM17 (0.50) MMP8ADAM17MMP1FCER2CNR1
SCHEMBL7185090 0.83 MMP8 (0.55) MMP8ALOX15HSD17B10SMN1; SMN2MMP1
SCHEMBL7172650 0.83 NPC1 (0.47) SMN1; SMN2MMP1MAPTKDM4ENPC1
SCHEMBL7173680 0.82 ALDH1A1 (0.41) MMP8ALOX15HSD17B10SMN1; SMN2KDM4E
SCHEMBL7178370 0.81 PPARG (0.46) SMN1; SMN2MMP1KDM4ENPC1RAB9A
SCHEMBL7192046 0.77 MMP3 (0.52) ADAM17MMP1NPC1RAB9AKMT2A
SCHEMBL7174719 0.76 NPC1 (0.45) SMN1; SMN2MMP1MAPTKDM4ENPC1
SCHEMBL7177458 0.75 MMP8 (0.52) MMP8MMP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576628-B1 Matrix metalloprotease inhibitors; arthritis, corneal ulcers, arteriosclerosis ROCHE DIAGNOSTICS GMBH (DE) 2003-06-10 US disclosed
EP-1005449-B1 3-ARYL-SUCCINAMIDO-HYDROXAMIC ACIDS, METHODS FOR PRODUCING SAID ACIDS AND MEDICAMENTS CONTAINING THE SAME ROCHE DIAGNOSTICS GMBH (DE) 2002-10-30 EP disclosed
EP-0897908-A1 3-Aryl-succinamido-hydroxamic acids, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1999-02-24 EP disclosed